Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adenoviral Vector
12%
Adenovirus
40%
Adenovirus Type 5
12%
AIDS/HIV
35%
Antiretroviral
8%
Antiretroviral Therapy
40%
Antiviral Drugs
20%
Antiviral Prophylaxis
10%
Apoptosis
26%
Bacteremia
9%
Bloodstream Infection
9%
Cardiac Implantable Electronic Device Infection
30%
Cardiovascular Implantable Electronic Devices
20%
Casp8p41
9%
CD4 T Cells
17%
Cell Death
12%
Chronic Hepatitis C Virus Infection
10%
Clinical Features
10%
Clinical High Risk
11%
Clinical Management
9%
Clinical Manifestations
8%
Clinical Outcomes
24%
Clinical Presentation
11%
Clinical Trials
8%
Community-based Participatory Research
14%
Confidence Interval
23%
COVID-19
73%
COVID-19 Pandemic
11%
Cytomegalovirus
74%
Cytomegalovirus Disease
45%
Cytomegalovirus Infection
48%
Device Infection
8%
Endocarditis
8%
Epidemiology
13%
Fever
11%
Fungal Infection
8%
Ganciclovir
13%
Gene Therapy
9%
Haematopoietic Stem Cell Transplant Recipients
9%
Hepatitis C Virus
14%
High Risk
16%
Highly Active Antiretroviral Therapy (HAART)
8%
HIV Infection
22%
HIV Patients
16%
HIV Protease Inhibitors
9%
HIV-1 Infection
8%
Hospitalization
16%
Human Herpesvirus 6 (HHV-6)
17%
Human Immunodeficiency Virus Infection
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Immune Response
14%
Immunocompromised Host
8%
Immunocompromised Patients
10%
Immunosuppression
9%
Infected Cells
8%
Infectious Diseases
9%
Infective Endocarditis
14%
Influenza
8%
Kidney
8%
Kidney Transplant Recipients
11%
Liver
10%
Liver Transplant Recipients
22%
Liver Transplantation
31%
Lung Transplantation
15%
Mayo Clinic
18%
Meta-analysis
8%
Minnesota
16%
Moderate to Severe
9%
Monoclonal Antibody
11%
Mycobacterium Tuberculosis (M. tb)
8%
Odds Ratio
11%
Opportunistic Infections
21%
Periprosthetic Joint Infection
15%
Physical Activity
8%
Polyethylene Glycol
8%
Preemptive Therapy
9%
Propionic Acidemia
9%
Protease Inhibitors
14%
Research Partnerships
8%
Retroviral Infection
10%
Risk Factors
18%
Rochester
9%
Solid Organ
8%
Solid Organ Transplant
8%
Solid Organ Transplant Recipients
43%
Solid Organ Transplantation
28%
T Cell Response
8%
T Cells
14%
Toll-like
11%
Transplant Patients
9%
Transplant Recipients
29%
Transplantation
30%
Treatment of HIV Infection
9%
Tuberculosis
18%
United States
26%
Vaccination
18%
Viral
9%
Viral Infection
8%
Viral Load
9%
Virus
34%
Medicine and Dentistry
Adenoviridae
9%
Adverse Event
6%
Allograft
10%
Antibiotic Therapy
5%
Antibiotics
5%
Antiinfective Agent
9%
Antimicrobial Therapy
6%
Antiretroviral Therapy
10%
Antiviral Drug
7%
Antiviral Therapy
10%
Antivirus Agent
12%
Bloodstream Infection
16%
Cardiovascular System
31%
Clinical Feature
10%
Clinical Trial
8%
Clinician
7%
Cohort Analysis
6%
Cohort Effect
15%
Combination Therapy
5%
COVID-19
68%
Cryptococcosis
5%
Cytomegalovirus
58%
Cytomegalovirus Infection
57%
Device Infection
31%
Diseases
42%
Endocarditis
9%
Ganciclovir
7%
Gene Therapy
8%
Hazard Ratio
5%
Health Care Cost
5%
Heart Graft
5%
Hematopoietic Stem Cell Transplantation
13%
Hepatitis C
5%
Hepatitis C Virus
5%
Human Herpesvirus 6
11%
Human Immunodeficiency Virus
44%
Human Immunodeficiency Virus Infection
10%
Immigrant
10%
Immunocompromised Patient
11%
Immunosuppressive Treatment
10%
Implantable Automatic Defibrillator
6%
Infection
100%
Infectious Arthritis
10%
Infectious Complication
5%
Infectious Disease
9%
Infective Endocarditis
13%
Intensive Care Unit
5%
Kidney Graft
12%
Kidney Transplantation
7%
Left Ventricular Assist Device
6%
Letermovir
5%
Liver Graft
17%
Liver Transplantation
25%
Lung Transplantation
12%
Malignant Neoplasm
5%
Messenger RNA
6%
Meta-Analysis
7%
Monoclonal Antibody
13%
Mortality Rate
5%
Mycobacteria
5%
Mycosis
7%
Odds Ratio
7%
Opportunistic Infection
12%
Outpatient
6%
Pathogen
16%
Permanent Pacemaker
5%
Polymerase Chain Reaction
8%
Programmed Cell Death
7%
Propionic Acidemia
7%
Prosthetics
11%
Public Health
5%
Serotype
8%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Solid Organ Transplantation
21%
Systematic Review
10%
T Cell
8%
T-Helper Cell
6%
Valganciclovir
6%
Viremia
8%
Virus
18%
Virus Infection
10%